Search Orphan Drug Designations and Approvals
-
Generic Name: | 3,5,3'-triiodothyroacetate |
---|---|
Date Designated: | 09/20/2000 |
Orphan Designation: | Treatment of well-differentiated papillary, follicular or combined papillary/follicular carcinomas of the thyroid gland. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Elliot Danforth, Jr., M.D. University of Vermont 84 Beartown Road Underhill, Vermont 05489 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-